Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

BackgroundThe prevalence, determinants and prognosis of pulmonary hypertension among long-term hemodialysis patients in the USA are poorly understood.MethodsA cross-sectional survey of prevalence and determinants of pulmonary hypertension was performed, followed by longitudinal follow-up for all-cause mortality. Pulmonary hypertension was defined as an estimated systolic pulmonary artery pressure of >35 mmHg using echocardiograms performed within an hour after the end of dialysis.ResultsPrevalent in 110/288 patients (38), the independent determinants of pulmonary hypertension were the following: left atrial diameter (odds ratio 10.1 per cm/m2, P < 0.0001), urea reduction ratio (odds ratio 0.94 per , P < 0.01) and vitamin D receptor activator use (odds ratio 0.41 for users, P < 0.01). Over a median follow-up of 2.15 years, 97 (34) patients died yielding a crude mortality rate (CMR) of 114.2 per 1000 patient-years. Of these, 58 deaths occurred among 110 patients with pulmonary hypertension (53, CMR 168.9/1000 patient-years) and 39 among 178 without pulmonary hypertension (22, CMR 52.5/1000 patient-years) [unadjusted hazard ratio (HR) for death 2.12 (95 confidence interval 1.41-3.19), P < 0.001]. After multivariate adjustment, pulmonary hypertension remained an independent predictor for all-cause mortality [HR 2.17 (95 confidence interval 1.31-3.61), P < 0.01].ConclusionsAmong hemodialysis patients, pulmonary hypertension is common and is strongly associated with an enlarged left atrium and poor long-term survival. Reducing left atrial size such as through volume control may be an attractive target to improve pulmonary hypertension. Improving pulmonary hypertension in this group of patients may improve the dismal outcomes.

Original languageEnglish (US)
Pages (from-to)3908-3914
Number of pages7
JournalNephrology Dialysis Transplantation
Volume27
Issue number10
DOIs
StatePublished - Oct 1 2012

Fingerprint

Pulmonary Hypertension
Renal Dialysis
Mortality
Odds Ratio
Confidence Intervals
Calcitriol Receptors
Heart Atria
Pulmonary Artery
Urea
Dialysis
Cross-Sectional Studies
Pressure
Survival

Keywords

  • epidemiology
  • hemodialysis
  • pulmonary hypertension
  • risk factors
  • survival

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Cite this

Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients. / Agarwal, Rajiv.

In: Nephrology Dialysis Transplantation, Vol. 27, No. 10, 01.10.2012, p. 3908-3914.

Research output: Contribution to journalArticle

@article{b66e8c50e5114bce9f97b6f278ca8145,
title = "Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients",
abstract = "BackgroundThe prevalence, determinants and prognosis of pulmonary hypertension among long-term hemodialysis patients in the USA are poorly understood.MethodsA cross-sectional survey of prevalence and determinants of pulmonary hypertension was performed, followed by longitudinal follow-up for all-cause mortality. Pulmonary hypertension was defined as an estimated systolic pulmonary artery pressure of >35 mmHg using echocardiograms performed within an hour after the end of dialysis.ResultsPrevalent in 110/288 patients (38), the independent determinants of pulmonary hypertension were the following: left atrial diameter (odds ratio 10.1 per cm/m2, P < 0.0001), urea reduction ratio (odds ratio 0.94 per , P < 0.01) and vitamin D receptor activator use (odds ratio 0.41 for users, P < 0.01). Over a median follow-up of 2.15 years, 97 (34) patients died yielding a crude mortality rate (CMR) of 114.2 per 1000 patient-years. Of these, 58 deaths occurred among 110 patients with pulmonary hypertension (53, CMR 168.9/1000 patient-years) and 39 among 178 without pulmonary hypertension (22, CMR 52.5/1000 patient-years) [unadjusted hazard ratio (HR) for death 2.12 (95 confidence interval 1.41-3.19), P < 0.001]. After multivariate adjustment, pulmonary hypertension remained an independent predictor for all-cause mortality [HR 2.17 (95 confidence interval 1.31-3.61), P < 0.01].ConclusionsAmong hemodialysis patients, pulmonary hypertension is common and is strongly associated with an enlarged left atrium and poor long-term survival. Reducing left atrial size such as through volume control may be an attractive target to improve pulmonary hypertension. Improving pulmonary hypertension in this group of patients may improve the dismal outcomes.",
keywords = "epidemiology, hemodialysis, pulmonary hypertension, risk factors, survival",
author = "Rajiv Agarwal",
year = "2012",
month = "10",
day = "1",
doi = "10.1093/ndt/gfr661",
language = "English (US)",
volume = "27",
pages = "3908--3914",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients

AU - Agarwal, Rajiv

PY - 2012/10/1

Y1 - 2012/10/1

N2 - BackgroundThe prevalence, determinants and prognosis of pulmonary hypertension among long-term hemodialysis patients in the USA are poorly understood.MethodsA cross-sectional survey of prevalence and determinants of pulmonary hypertension was performed, followed by longitudinal follow-up for all-cause mortality. Pulmonary hypertension was defined as an estimated systolic pulmonary artery pressure of >35 mmHg using echocardiograms performed within an hour after the end of dialysis.ResultsPrevalent in 110/288 patients (38), the independent determinants of pulmonary hypertension were the following: left atrial diameter (odds ratio 10.1 per cm/m2, P < 0.0001), urea reduction ratio (odds ratio 0.94 per , P < 0.01) and vitamin D receptor activator use (odds ratio 0.41 for users, P < 0.01). Over a median follow-up of 2.15 years, 97 (34) patients died yielding a crude mortality rate (CMR) of 114.2 per 1000 patient-years. Of these, 58 deaths occurred among 110 patients with pulmonary hypertension (53, CMR 168.9/1000 patient-years) and 39 among 178 without pulmonary hypertension (22, CMR 52.5/1000 patient-years) [unadjusted hazard ratio (HR) for death 2.12 (95 confidence interval 1.41-3.19), P < 0.001]. After multivariate adjustment, pulmonary hypertension remained an independent predictor for all-cause mortality [HR 2.17 (95 confidence interval 1.31-3.61), P < 0.01].ConclusionsAmong hemodialysis patients, pulmonary hypertension is common and is strongly associated with an enlarged left atrium and poor long-term survival. Reducing left atrial size such as through volume control may be an attractive target to improve pulmonary hypertension. Improving pulmonary hypertension in this group of patients may improve the dismal outcomes.

AB - BackgroundThe prevalence, determinants and prognosis of pulmonary hypertension among long-term hemodialysis patients in the USA are poorly understood.MethodsA cross-sectional survey of prevalence and determinants of pulmonary hypertension was performed, followed by longitudinal follow-up for all-cause mortality. Pulmonary hypertension was defined as an estimated systolic pulmonary artery pressure of >35 mmHg using echocardiograms performed within an hour after the end of dialysis.ResultsPrevalent in 110/288 patients (38), the independent determinants of pulmonary hypertension were the following: left atrial diameter (odds ratio 10.1 per cm/m2, P < 0.0001), urea reduction ratio (odds ratio 0.94 per , P < 0.01) and vitamin D receptor activator use (odds ratio 0.41 for users, P < 0.01). Over a median follow-up of 2.15 years, 97 (34) patients died yielding a crude mortality rate (CMR) of 114.2 per 1000 patient-years. Of these, 58 deaths occurred among 110 patients with pulmonary hypertension (53, CMR 168.9/1000 patient-years) and 39 among 178 without pulmonary hypertension (22, CMR 52.5/1000 patient-years) [unadjusted hazard ratio (HR) for death 2.12 (95 confidence interval 1.41-3.19), P < 0.001]. After multivariate adjustment, pulmonary hypertension remained an independent predictor for all-cause mortality [HR 2.17 (95 confidence interval 1.31-3.61), P < 0.01].ConclusionsAmong hemodialysis patients, pulmonary hypertension is common and is strongly associated with an enlarged left atrium and poor long-term survival. Reducing left atrial size such as through volume control may be an attractive target to improve pulmonary hypertension. Improving pulmonary hypertension in this group of patients may improve the dismal outcomes.

KW - epidemiology

KW - hemodialysis

KW - pulmonary hypertension

KW - risk factors

KW - survival

UR - http://www.scopus.com/inward/record.url?scp=84864398835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864398835&partnerID=8YFLogxK

U2 - 10.1093/ndt/gfr661

DO - 10.1093/ndt/gfr661

M3 - Article

C2 - 22290987

AN - SCOPUS:84864398835

VL - 27

SP - 3908

EP - 3914

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 10

ER -